Type |
Details |
Score |
Allele |
Name: |
BCL6 interacting corepressor; targeted mutation 2a, Wellcome Trust Sanger Institute |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready, Null/knockout, Reporter |
|
•
•
•
•
•
|
Allele |
Name: |
BCL6 co-repressor-like 1; targeted mutation 2a, Wellcome Trust Sanger Institute |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready, Null/knockout, Reporter |
|
•
•
•
•
•
|
Allele |
Name: |
BCL6 interacting corepressor; targeted mutation 1.1, Vivian J Bardwell |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
Allele |
Name: |
BCL6 interacting corepressor; targeted mutation 1.1, Atsushi Iwama |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
Allele |
Name: |
BCL6 interacting corepressor; targeted mutation 1, Paolo Sportoletti |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
Allele |
Name: |
BCL6 co-repressor-like 1; endonuclease-mediated mutation 1, The Centre for Phenogenomics |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Allele |
Name: |
BCL6 interacting corepressor; endonuclease-mediated mutation 1, GemPharmatech Co., Ltd |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Conditional ready, No functional change |
|
•
•
•
•
•
|
Allele |
Name: |
BCL6 co-repressor-like 1; endonuclease-mediated mutation 6, GemPharmatech Co., Ltd |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Allele |
Name: |
BCL6 co-repressor-like 1; endonuclease-mediated mutation 1, Shanghai Model Organisms Center |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Allele |
Name: |
BCL6 interacting corepressor; targeted mutation 2, Vivian J Bardwell |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready, Null/knockout |
|
•
•
•
•
•
|
Allele |
Name: |
BCL6 interacting corepressor; targeted mutation 2.1, Vivian J Bardwell |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Bcor/? |
Background: |
chimera involves: 129P2/OlaHsd |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Regulatory Region |
Type: |
enhancer |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Publication |
First Author: |
Lefebure M |
Year: |
2017 |
Journal: |
Nat Commun |
Title: |
Genomic characterisation of Eμ-Myc mouse lymphomas identifies Bcor as a Myc co-operative tumour-suppressor gene. |
Volume: |
8 |
|
Pages: |
14581 |
|
•
•
•
•
•
|
Allele |
Name: |
B cell leukemia/lymphoma 6; endonuclease-mediated mutation 1, Shanghai Model Organisms Center |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Publication |
First Author: |
Baron BW |
Year: |
2015 |
Journal: |
Biochim Biophys Acta |
Title: |
The ITM2B (BRI2) gene is a target of BCL6 repression: Implications for lymphomas and neurodegenerative diseases. |
Volume: |
1852 |
Issue: |
5 |
Pages: |
742-8 |
|
•
•
•
•
•
|
Interaction Experiment |
Description: |
Proteomics analysis of Ring1B/Rnf2 interactors identifies a novel complex with the Fbxl10/Jhdm1B histone demethylase and the Bcl6 interacting corepressor. |
|
•
•
•
•
•
|
Publication |
First Author: |
Feng D |
Year: |
2022 |
Journal: |
Nat Commun |
Title: |
Chromatin organizer SATB1 controls the cell identity of CD4(+) CD8(+) double-positive thymocytes by regulating the activity of super-enhancers. |
Volume: |
13 |
Issue: |
1 |
Pages: |
5554 |
|
•
•
•
•
•
|
Publication |
First Author: |
Takano J |
Year: |
2022 |
Journal: |
Nat Commun |
Title: |
PCGF1-PRC1 links chromatin repression with DNA replication during hematopoietic cell lineage commitment. |
Volume: |
13 |
Issue: |
1 |
Pages: |
7159 |
|
•
•
•
•
•
|
Allele |
Name: |
BCL6 interacting corepressor; gene trap IST13937F1, Texas A&M Institute for Genomic Medicine |
Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
Allele |
Name: |
BCL6 interacting corepressor; gene trap IST14238F4, Texas A&M Institute for Genomic Medicine |
Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
Allele |
Name: |
BCL6 interacting corepressor; gene trap IST14679B10, Texas A&M Institute for Genomic Medicine |
Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
Allele |
Name: |
BCL6 interacting corepressor; gene trap IST14685C3, Texas A&M Institute for Genomic Medicine |
Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
Allele |
Name: |
BCL6 interacting corepressor; gene trap IST14861C9, Texas A&M Institute for Genomic Medicine |
Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
Allele |
Name: |
BCL6 co-repressor-like 1; gene trap IST15052G2, Texas A&M Institute for Genomic Medicine |
Allele Type: |
Gene trapped |
|
|
•
•
•
•
•
|
Strain |
Attribute String: |
mutant strain, congenic, targeted mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
targeted mutation, mutant stock |
|
•
•
•
•
•
|
Allele |
Name: |
BCL6 co-repressor-like 1; endonuclease-mediated mutation 1, Model Animal Research Center of Nanjing University |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Null/knockout |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, mutant strain, endonuclease-mediated mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, mutant strain, endonuclease-mediated mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, mutant strain, endonuclease-mediated mutation |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Bcor/? |
Background: |
chimera involves: 129S1/Sv * 129X1/SvJ |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Bcor/? |
Background: |
chimera involves: 129P2/OlaHsd |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Bcor/? |
Background: |
chimera involves: 129S2/SvPas |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Bcor/? |
Background: |
chimera involves: 129S2/SvPas |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Bcor/? |
Background: |
involves: 129S1/Sv |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Bcorl1/? |
Background: |
C57BL/6NCrl-Bcorl1/Cmmr |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Bcorl1/Bcorl1 |
Background: |
C57BL/6NCrl-Bcorl1/Cmmr |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Bcorl1/? |
Background: |
C57BL/6N-Bcorl1/Cmmr |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Bcorl1/Bcorl1 |
Background: |
C57BL/6N-Bcorl1/Cmmr |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Isshiki Y |
Year: |
2019 |
Journal: |
Blood Adv |
Title: |
KDM2B in polycomb repressive complex 1.1 functions as a tumor suppressor in the initiation of T-cell leukemogenesis. |
Volume: |
3 |
Issue: |
17 |
Pages: |
2537-2549 |
|
•
•
•
•
•
|
Allele |
Name: |
immunoglobulin heavy constant mu; targeted mutation 1, Riccardo Dalla-Favera |
Allele Type: |
Targeted |
Attribute String: |
Humanized sequence, Inserted expressed sequence |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, mutant strain, endonuclease-mediated mutation |
|
•
•
•
•
•
|
Publication |
First Author: |
Srinivasan RS |
Year: |
2003 |
Journal: |
Oncogene |
Title: |
The mixed lineage leukemia fusion partner AF9 binds specific isoforms of the BCL-6 corepressor. |
Volume: |
22 |
Issue: |
22 |
Pages: |
3395-406 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
coisogenic, endonuclease-mediated mutation, mutant strain |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Bcorl1/? |
Background: |
C57BL/6J-Bcorl1 |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Phan RT |
Year: |
2007 |
Journal: |
Nat Immunol |
Title: |
Genotoxic stress regulates expression of the proto-oncogene Bcl6 in germinal center B cells. |
Volume: |
8 |
Issue: |
10 |
Pages: |
1132-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Basso K |
Year: |
2012 |
Journal: |
J Exp Med |
Title: |
BCL6 positively regulates AID and germinal center gene expression via repression of miR-155. |
Volume: |
209 |
Issue: |
13 |
Pages: |
2455-65 |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 83, Takahashi Tokuhisa |
Allele Type: |
Transgenic |
Attribute String: |
Inserted expressed sequence |
|
•
•
•
•
•
|
Publication |
First Author: |
Gearhart MD |
Year: |
2006 |
Journal: |
Mol Cell Biol |
Title: |
Polycomb group and SCF ubiquitin ligases are found in a novel BCOR complex that is recruited to BCL6 targets. |
Volume: |
26 |
Issue: |
18 |
Pages: |
6880-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Apollonio B |
Year: |
2023 |
Journal: |
J Clin Invest |
Title: |
Tumor-activated lymph node fibroblasts suppress T cell function in diffuse large B cell lymphoma. |
Volume: |
133 |
Issue: |
13 |
|
|
•
•
•
•
•
|
Allele |
Name: |
regulatory region 394; endonuclease-mediated mutation 1, Bingtao Hao |
Allele Type: |
Endonuclease-mediated |
Attribute String: |
Modified regulatory region, Null/knockout |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Ighm/? |
Background: |
involves: 129/Sv * C57BL/6 |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Takamori M |
Year: |
2004 |
Journal: |
Int Immunol |
Title: |
BAZF is required for activation of naive CD4 T cells by TCR triggering. |
Volume: |
16 |
Issue: |
10 |
Pages: |
1439-49 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Bcor/? Commd10/Commd10<+> |
Background: |
involves: 129S1/Sv * C57BL/6 * CBA/Ca |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Bcor/? H2az2/H2az2<+> |
Background: |
involves: 129S1/Sv * C57BL/6J * CBA/J |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Bcor/? Pax3/Pax3<+> |
Background: |
involves: 129S1/Sv * C57BL/6J |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Bcor/Bcor<+> Tmem163/Tmem163<+> |
Background: |
involves: 129S1/Sv * C57BL/6N * FVB/N |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Bcor/? Tmem163/Tmem163<+> |
Background: |
involves: 129S1/Sv * C57BL/6N * FVB/N |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Bcor/? Isl1/Isl1<+> |
Background: |
involves: 129S1/Sv |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Hatzi K |
Year: |
2013 |
Journal: |
Cell Rep |
Title: |
A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters. |
Volume: |
4 |
Issue: |
3 |
Pages: |
578-88 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hamline MY |
Year: |
2020 |
Journal: |
Dev Biol |
Title: |
OFCD syndrome and extraembryonic defects are revealed by conditional mutation of the Polycomb-group repressive complex 1.1 (PRC1.1) gene BCOR. |
Volume: |
468 |
Issue: |
1-2 |
Pages: |
110-132 |
|
•
•
•
•
•
|
DO Term |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 1, Beverly Baron |
Allele Type: |
Transgenic |
Attribute String: |
Inducible, Inserted expressed sequence |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 2, Beverly Baron |
Allele Type: |
Transgenic |
Attribute String: |
Inducible, Inserted expressed sequence |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Rr394/Rr394 |
Background: |
Not Specified |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Mondello P |
Year: |
2020 |
Journal: |
Cancer Discov |
Title: |
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma. |
Volume: |
10 |
Issue: |
3 |
Pages: |
440-459 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Bcor/Bcor<+> Isl1/Isl1<+> |
Background: |
involves: 129S1/Sv |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Hasegawa N |
Year: |
2017 |
Journal: |
Leukemia |
Title: |
Impact of combinatorial dysfunctions of Tet2 and Ezh2 on the epigenome in the pathogenesis of myelodysplastic syndrome. |
Volume: |
31 |
Issue: |
4 |
Pages: |
861-871 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jeon BN |
Year: |
2012 |
Journal: |
Cancer Res |
Title: |
KR-POK interacts with p53 and represses its ability to activate transcription of p21WAF1/CDKN1A. |
Volume: |
72 |
Issue: |
5 |
Pages: |
1137-48 |
|
•
•
•
•
•
|
Publication |
First Author: |
Pasqualucci L |
Year: |
2008 |
Journal: |
Nat Genet |
Title: |
AID is required for germinal center-derived lymphomagenesis. |
Volume: |
40 |
Issue: |
1 |
Pages: |
108-12 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Bcl6/Bcl6 Ighm/? |
Background: |
involves: 129/Sv * 129S1/Sv * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Hatzi K |
Year: |
2019 |
Journal: |
Nat Immunol |
Title: |
Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesis. |
Volume: |
20 |
Issue: |
1 |
Pages: |
86-96 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rose NR |
Year: |
2016 |
Journal: |
Elife |
Title: |
RYBP stimulates PRC1 to shape chromatin-based communication between Polycomb repressive complexes. |
Volume: |
5 |
|
|
|
•
•
•
•
•
|
HT Experiment |
Series Id: |
GSE22371 |
Experiment Type: |
transcription profiling by array |
Study Type: |
WT vs. Mutant |
Source: |
ArrayExpress |
|
•
•
•
•
•
|
Publication |
First Author: |
Chiang C |
Year: |
2014 |
Journal: |
Cancer Cell |
Title: |
Controlling COR competence: BCL-6 regulates neurogenesis and tumor suppression. |
Volume: |
26 |
Issue: |
6 |
Pages: |
773-774 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zeisig BB |
Year: |
2016 |
Journal: |
Cancer Cell |
Title: |
Combinatorial Tethering: A Novel Mode to Recruit Non-canonical PRC1 for Normal and Malignant GC B Cell Development. |
Volume: |
30 |
Issue: |
2 |
Pages: |
185-187 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rivas MA |
Year: |
2021 |
Journal: |
Nat Immunol |
Title: |
Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation. |
Volume: |
22 |
Issue: |
2 |
Pages: |
240-253 |
|
•
•
•
•
•
|
Strain |
Attribute String: |
transgenic, targeted mutation, mutant strain, congenic |
|
•
•
•
•
•
|
Publication |
First Author: |
Bedekovics T |
Year: |
2016 |
Journal: |
Blood |
Title: |
UCH-L1 is induced in germinal center B cells and identifies patients with aggressive germinal center diffuse large B-cell lymphoma. |
Volume: |
127 |
Issue: |
12 |
Pages: |
1564-74 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Atmin/Atmin Ighm/Ighm<+> Tg(Fcer2a-cre)5Mbu/? |
Background: |
B6.Cg-Atmin Ighm Tg(Fcer2a-cre)5Mbu |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Rengaraj D |
Year: |
2007 |
Journal: |
Endocrine |
Title: |
Expression and regulation of type II integral membrane protein family members in mouse male reproductive tissues. |
Volume: |
31 |
Issue: |
2 |
Pages: |
193-201 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hedlund J |
Year: |
2009 |
Journal: |
BMC Res Notes |
Title: |
BRICHOS - a superfamily of multidomain proteins with diverse functions. |
Volume: |
2 |
|
Pages: |
180 |
|
•
•
•
•
•
|
Publication |
First Author: |
Knight SD |
Year: |
2013 |
Journal: |
Biochemistry |
Title: |
The BRICHOS domain, amyloid fibril formation, and their relationship. |
Volume: |
52 |
Issue: |
43 |
Pages: |
7523-31 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tai TS |
Year: |
2014 |
Journal: |
PLoS One |
Title: |
Itm2a, a target gene of GATA-3, plays a minimal role in regulating the development and function of T cells. |
Volume: |
9 |
Issue: |
5 |
Pages: |
e96535 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fotinopoulou A |
Year: |
2005 |
Journal: |
J Biol Chem |
Title: |
BRI2 interacts with amyloid precursor protein (APP) and regulates amyloid beta (Abeta) production. |
Volume: |
280 |
Issue: |
35 |
Pages: |
30768-72 |
|
•
•
•
•
•
|
Publication |
First Author: |
Peng S |
Year: |
2010 |
Journal: |
Biochem Biophys Res Commun |
Title: |
The extracellular domain of Bri2 (ITM2B) binds the ABri peptide (1-23) and amyloid beta-peptide (Abeta1-40): Implications for Bri2 effects on processing of amyloid precursor protein and Abeta aggregation. |
Volume: |
393 |
Issue: |
3 |
Pages: |
356-61 |
|
•
•
•
•
•
|
Publication |
First Author: |
Matsuda S |
Year: |
2009 |
Journal: |
J Biol Chem |
Title: |
BRI3 inhibits amyloid precursor protein processing in a mechanistically distinct manner from its homologue dementia gene BRI2. |
Volume: |
284 |
Issue: |
23 |
Pages: |
15815-25 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
The family of type 2 integral membrane protein (ITM2) consists of three members, ITM2A, ITM2B and ITM2C []. Members of this family contain a BRICHOS domain, which possesses chaperone activity [,].ITM2A is a target gene of GATA-3, a T cell-specific transcription factor [].ITM2B is proteolytically cleaved at three locations; cleavage by furin in the C-terminal region generates a 23-residue peptide (ABri23), processing by ADAM10 results in release of the BRICHOS domain from the membrane-bound N-terminal part and intramembrane cleavage by SPPL2a/2b liberates the intracellular domain []. ITM2B (BRI2) is a target of BCL6 transcriptional repression and a short form of the ITM2B protein, similarly to other targets of BCL6, induces apoptosis in hematopoietic cell lines []. ITM2B interacts with amyloid precursor protein (APP) and regulates amyloid beta (Abeta) production [, ]. ITM2C (BRI3) also inhibits amyloid precursor protein processing, but through a different mechanism to ITM2B []. |
|
•
•
•
•
•
|
Publication |
First Author: |
The Centre for Phenogenomics |
Year: |
2022 |
Journal: |
MGI Direct Data Submission |
Title: |
Direct Data Submission for The Centre for Phenogenomics Alleles. |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Tomsig JL |
Year: |
2003 |
Journal: |
J Biol Chem |
Title: |
Identification of targets for calcium signaling through the copine family of proteins. Characterization of a coiled-coil copine-binding motif. |
Volume: |
278 |
Issue: |
12 |
Pages: |
10048-54 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gu X |
Year: |
2016 |
Journal: |
Blood |
Title: |
AID-associated DNA repair pathways regulate malignant transformation in a murine model of BCL6-driven diffuse large B-cell lymphoma. |
Volume: |
127 |
Issue: |
1 |
Pages: |
102-12 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wesemann DR |
Year: |
2011 |
Journal: |
J Exp Med |
Title: |
Immature B cells preferentially switch to IgE with increased direct Sμ to Sε recombination. |
Volume: |
208 |
Issue: |
13 |
Pages: |
2733-46 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fangazio M |
Year: |
2021 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphoma. |
Volume: |
118 |
Issue: |
22 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Hori M |
Year: |
2001 |
Journal: |
Blood Cells Mol Dis |
Title: |
Non-Hodgkin lymphomas of mice. |
Volume: |
27 |
Issue: |
1 |
Pages: |
217-22 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
269
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
263
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
266
 |
Fragment?: |
false |
|
•
•
•
•
•
|